Evogene LTD Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ

14 Aug 2026

EVGN

SCHEDULE: Armistice Capital Discloses 4.99% Stake in Evogene Ltd.

Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 713,539 ordinary shares, representing 4.99% of Evogene Ltd.'s outstanding shares.

NASDAQ

15 May 2026

EVGN

Evogene LTD

SCHEDULE: Armistice Capital Discloses 9.99% Stake in Evogene Ltd.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 9.99% of Evogene Ltd.'s ordinary shares as of March 31, 2026.